Finasteride in hospitalized adult males with COVID-19: A risk factor for severity of the disease or an adjunct treatment: A randomized controlled clinical trial

Background: There is controversy about the efficacy of 5-alpha-reductase inhibitors in COVID-19 patients. Some assumed that finasteride might be a risk factor for deterioration and others proposed it as a possible adjunct treatment for moderate to severe COVID-19 infection in the elderly. Methods: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarehoseinzade, Elham, Allami, Abbas, Ahmadi, Mehrnoosh, Bijani, Behzad, Mohammadi, Navid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214036/
https://www.ncbi.nlm.nih.gov/pubmed/34169042
http://dx.doi.org/10.47176/mjiri.35.30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214036/
https://www.ncbi.nlm.nih.gov/pubmed/34169042
http://dx.doi.org/10.47176/mjiri.35.30

Ejemplares similares